MET and non-small cell lung carcinoma: In addition, in a cohort of 196 NSCLC brain metastasis samples, Presseur et al. found C-MET gene amplification and overexpression in 21.6 and 44.4%, respectively, confirming that C-MET is commonly activated in brain metastasis manifestation (90).